Expert consensus on maintenance treatment for metastatic colorectal cancer in China
作者： Rui-Hua Xu , Lin Shen , Jin Li , Jian-Ming Xu , Feng Bi
DOI: 10.1186/S40880-015-0067-X
关键词: Clinical trial 、 Phases of clinical research 、 Colorectal cancer 、 Oncology 、 Quality of life 、 Maintenance therapy 、 MEDLINE 、 Expert consensus 、 Internal medicine 、 Medicine 、 Survival analysis
摘要: The impact of maintenance therapy on progression-free survival and overall as well quality life Chinese patients with metastatic colorectal cancer has long been under discussion. Recently, some phase III clinical trials have revealed that can significantly prolong the while maintain an acceptable safety profile. Based this evidence common treatment practice in China, we now generated one Expert Consensus Maintenance Treatment for Metastatic Colorectal Cancer China to further specify necessity therapy, suitable candidates such treatment, appropriate regimens.
biomedcentral.com
springer.com
core.ac.uk
utsystem.edu 参考文章(27)
Dirk Arnold, Ullrich Graeven, Christian A. Lerchenmuller, Brigitta Killing, Reinhard Depenbusch, Claus-Christoph Steffens, Salah-Eddin Al-Batran, Thoralf Lange, Georg Dietrich, Jan Stoehlmacher, Andrea Tannapfel, Hans-Joachim Schmoll, Anke Reinacher-Schick, Susanna Hegewisch-Becker, Maintenance strategy with fluoropyrimidines (FP) plus Bevacizumab (Bev), Bev alone, or no treatment, following a standard combination of FP, oxaliplatin (Ox), and Bev as first-line treatment for patients with metastatic colorectal cancer (mCRC): A phase III non-inferiority trial (AIO KRK 0207). Journal of Clinical Oncology. ,vol. 32, pp. 3503- 3503 ,(2014) , 10.1200/JCO.2014.32.15_SUPPL.3503
Feng Wang, Long Bai, Tian-Shu Liu, Yi-Yi Yu, Ming-Ming He, Kai-Yan Liu, Hui-Yan Luo, Dong-Sheng Zhang, Yin Jin, Feng-Hua Wang, Zhi-Qiang Wang, De-Shen Wang, Miao-Zhen Qiu, Chao Ren, Yu-Hong Li, Rui-Hua Xu, Right- and left-sided colorectal cancers respond differently to cetuximab Chinese Journal of Cancer. ,vol. 34, pp. 24- ,(2015) , 10.1186/S40880-015-0022-X
Yan Li, Jing Li, Ming Lu, Xi-cheng Wang, Lin Shen, Capecitabine Maintenance Therapy after First-Line Chemotherapy in Patients with Metastatic Colorectal Cancer Chinese Journal of Cancer Research. ,vol. 22, pp. 181- 185 ,(2010) , 10.1007/S11670-010-0181-X
J. Randolph Hecht, Edith Mitchell, Tarek Chidiac, Carroll Scroggin, Christopher Hagenstad, David Spigel, John Marshall, Allen Cohn, David McCollum, Philip Stella, Robert Deeter, Seta Shahin, Rafael G. Amado, A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer Journal of Clinical Oncology. ,vol. 27, pp. 672- 680 ,(2009) , 10.1200/JCO.2008.19.8135
Long Bai, Dong-sheng Zhang, Wen-jing Wu, Chao Ren, De-shen Wang, Feng Wang, Miao-zhen Qiu, Rui-hua Xu, Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment. Medical Oncology. ,vol. 32, pp. 469- 469 ,(2015) , 10.1007/S12032-014-0469-7
Hailong Shi, Jinling Jiang, Jun Ji, Min Shi, Qu Cai, Xuehua Chen, Yingyan Yu, Bingya Liu, Zhenggang Zhu, Jun Zhang, Anti-angiogenesis participates in antitumor effects of metronomic capecitabine on colon cancer. Cancer Letters. ,vol. 349, pp. 128- 135 ,(2014) , 10.1016/J.CANLET.2014.04.002
Suayib Yalcin, Ruchan Uslu, Faysal Dane, Ugur Yilmaz, Nurullah Zengin, Evin Buyukunal, Suleyman Buyukberber, Celalettin Camci, Orhan Sencan, Sadettin Kilickap, Fatih Ozdener, Duygu Cevik, Bevacizumab + Capecitabine as Maintenance Therapy after Initial Bevacizumab + XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase III ‘Stop and Go' Study Results - A Turkish Oncology Group Trial Oncology. ,vol. 85, pp. 328- 335 ,(2013) , 10.1159/000355914
Wanqing Chen, Rongshou Zheng, Hongmei Zeng, Siwei Zhang, The incidence and mortality of major cancers in China, 2012. Chinese Journal of Cancer. ,vol. 35, pp. 73- 73 ,(2013) , 10.1186/S40880-016-0137-8
Zhong-Zhen Guan, Jian-Ming Xu, Rong-Cheng Luo, Feng-Yi Feng, Li-Wei Wang, Lin Shen, Shi-Ying Yu, Yi Ba, Jun Liang, Dong Wang, Shu-Kui Qin, Jie-Jun Wang, Jing He, Chuan Qi, Rui-Hua Xu, Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial Chinese Journal of Cancer. ,vol. 30, pp. 682- 689 ,(2011) , 10.5732/CJC.011.10188
Hui-Yan Luo, Rui-Hua Xu, Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer. World Journal of Gastroenterology. ,vol. 20, pp. 3858- 3874 ,(2014) , 10.3748/WJG.V20.I14.3858